Medicine City

China Pharmaceutical City

China Pharmaceutical City, located in Taizhou, an important member city of the Yangtze River Delta, with a total planning area of 30 square kilometers, is composed of scientific research and development zone, production and manufacturing zone, exhibition and trading zone, health care zone, education and teaching zone, comprehensive supporting zone and other functional areas. It is the first national pharmaceutical high-tech zone in China, which is jointly built by the Ministry of Science and Technology, the National Health Commission, the State Drug Administration, the State Administration of Traditional Chinese Medicine and the People’s Government of Jiangsu Province.

Since the start of the construction of China Pharmaceutical City, it has been committed to building the largest and most complete bio pharmaceutical industry base in China according to the planning and construction concept of “prospering the city with industry, promoting production with city, integrating industry and city, and co prosperity of industry and city”. At present, more than 70 well-known universities and pharmaceutical research and development institutions at home and abroad have gathered in the zone, and more than 1000 well-known pharmaceutical enterprises at home and abroad have settled in the zone, including Nestle, AstraZeneca, Takeda Pharmaceutical, Boehringer Ingelheim, Shiyao Group, and Haiwang Pharmaceutical; More than 1900 “international first-class, domestic leading” medical innovation achievements have been successfully applied; More than 3800 high-level talents from home and abroad settled down to start their own businesses; The park has been listed as the development pilot of the national new vaccine and specific diagnostic reagent industry cluster; The development area has exceeded 20 square kilometers.